Modulation of OPRM1 alternative splicing by morphine and HIV-1 Nef
吗啡和 HIV-1 Nef 对 OPRM1 选择性剪接的调节
基本信息
- 批准号:10654016
- 负责人:
- 金额:$ 34.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Alternative SplicingAntisense OligonucleotidesAutopsyBehaviorBindingBiochemicalBrainBrain regionC-terminalCell Culture TechniquesCellsChronicClinicalConsensusCyclic AMPDataDevelopmentDrug abuseElementsEventExonsExposure toFamilyFunctional disorderG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGene ActivationHIVHIV Envelope Protein gp120HIV InfectionsHIV-1HIV/AIDSHeroinHumanIllicit DrugsIn VitroInbred F344 RatsIncidenceIndividualMediatingMessenger RNAModelingMolecularMorphineMorphine DependenceMuscarinic M1 ReceptorN-terminalNeurocognitiveNeurogliaNeuronsOpiate AddictionOpioid ReceptorOralPathologicPathway interactionsPeripheral Blood Mononuclear CellPersonsPhosphotransferasesPhysical DependencePhysical assessmentPhysiologicalProtein IsoformsProtein KinaseRNARNA SplicingRattusRecombinantsRegulationReportingResearchRewardsRoleSelf AdministrationSignal PathwaySignal TransductionSpinal CordTailTissuesTranscriptViralWithdrawalbrain tissueexosomeextracellular vesiclesgenetic regulatory proteinin vivomRNA Precursormembernef Proteinnovelopioid abuseopioid useresponsesecretory protein
项目摘要
PROJECT SUMMARY
This R01 application is in response to PAS-18-915 entitled “HIV/AIDS High Priority Drug Abuse Research”.
Our project will investigate the molecular and functional interactions between HIV and morphine in regulation of
alternative pre-mRNA splicing of the opioid receptor M1 (OPRM1) with implications for enhanced opioid
dependence observed in the people with HIV (PWH). Clinically used opioids, such as morphine, as well as
illicit drugs, such as heroin, activate OPRM1 that is a member of the G protein-coupled receptor (GPCR)
family. OPRM1 pre-mRNA undergoes extensive alternative splicing events. To date, 21 isoforms of the human
OPRM1 with alternative C-terminal and/or N-terminal regions and 17 isoforms of the rat OPRM1, have been
identified. Given the importance of these regions in G protein-coupled receptor (GPCR) signaling, differential
regulation of OPRM1 isoforms would have functional consequences. However, characterization of OPRM1
signaling is generalized, and only one isoform (MOR1) has been extensively studied. Our preliminary data
suggest that expression of splicing regulatory protein SRSF1 and alternative splicing of MOR-1X is
preferentially induced in neuronal cells exposed to morphine. Interestingly, our results also revealed that
alternative splicing and expression of MOR-1X isoform is induced in postmortem brain tissues obtained from
the PWH. These results suggested that HIV and morphine may impact OPRM1 alternative splicing and
synergistically induce MOR-1X isoform expression. The mutually exclusive exon X of OPRM1 pre-mRNA is
incorporated into the mature mRNA transcript following exon 3 in the MOR-1X mRNA transcript. This insertion
results in substantially longer C-terminal tail having new motifs potentially binding with several cellular kinases
that is unique to the MOR-1X isoform. We recently reported that glial cells infected with HIV-1 release Nef
protein captured within the extracellular vesicles (Nef-EVs) which are readily taken up by neurons. We further
assessed possible role of Nef-EVs and two other HIV secretory proteins, Tat and gp120, in alternative splicing
of MOR-1X. Interestingly, while recombinant Tat and gp120 had no visible effects, treatment of neurons with
Nef-EVs caused a comparable induction in MOR-1X alternative splicing as did treatment with morphine. Our
preliminary results also revealed that co-treatment of neurons with Nef-EVs and morphine synergistically
induced MOR-1X alternative splicing. Additionally, alternative splicing of MOR-1X was induced in brain regions
involved in the reward pathways of the F344 rat that is the control strain of HIV-1Tg rat that has an additive
induction with the exposure to morphine. Taken all together, we hypothesize that HIV-1 contributes to the
increased rate of opioid dependence in the PWH by amplifying the rate of MOR-1X alternative splicing induced
by morphine. Our proposed studies will reveal a novel synergistic interaction between morphine and HIV on
alternative splicing of OPRM1 pre-mRNA leading to preferential expression of MOR-1X isoform with
implications in physical dependence of morphine.
项目摘要
本R 01申请是对PAS-18-915“HIV/AIDS高优先药物滥用研究”的回应。
我们的项目将研究HIV和吗啡之间的分子和功能相互作用,
阿片受体M1(OPRM 1)的前体mRNA选择性剪接与增强阿片
艾滋病毒感染者(PWH)的依赖性。临床使用的阿片类药物,如吗啡,以及
非法药物,如海洛因,激活OPRM 1,它是G蛋白偶联受体(GPCR)的成员
家人OPRM 1前mRNA经历广泛的选择性剪接事件。到目前为止,人类的21种亚型
具有交替的C-末端和/或N-末端区域的OPRM 1和大鼠OPRM 1的17种同种型,已经被发现。
鉴定考虑到这些区域在G蛋白偶联受体(GPCR)信号传导中的重要性,差异表达是可能的。
OPRM 1同种型的调节将具有功能性后果。然而,OPRM 1的表征
信号传导是普遍的,只有一种同种型(MOR 1)被广泛研究。我们的初步数据
提示剪接调节蛋白SRSF 1表达和莫尔-1X的选择性剪接,
优先在暴露于吗啡的神经元细胞中诱导。有趣的是,我们的结果还显示,
莫尔-1X同种型的选择性剪接和表达在死后脑组织中被诱导,所述死后脑组织获自
威尔斯亲王医院这些结果表明,HIV和吗啡可能影响OPRM 1的选择性剪接,
协同诱导莫尔-1X同种型表达。OPRM 1前体mRNA的互斥外显子X是
在莫尔-1X mRNA转录物中,在外显子3之后掺入成熟mRNA转录物中。该插入
导致具有潜在地与几种细胞激酶结合的新基序的显著更长的C-末端尾部
这是莫尔-1X同种型所特有的。我们最近报道了感染HIV-1的神经胶质细胞释放Nef
在细胞外囊泡(Nef-EV)内捕获的蛋白质,其容易被神经元摄取。我们进一步
评估了Nef-EV和其他两种HIV分泌蛋白达特和gp 120在选择性剪接中的可能作用
的莫尔-1X。有趣的是,虽然重组达特和gp 120没有明显的作用,但用
Nef-EV在莫尔-1X选择性剪接中引起的诱导与吗啡治疗相当。我们
初步结果还显示,用Nef-EV和吗啡协同处理神经元,
诱导莫尔-1X选择性剪接。此外,在脑区域中诱导了莫尔-1X的选择性剪接
参与F344大鼠的奖励途径,F344大鼠是具有添加剂的HIV-1 Tg大鼠的对照品系
吗啡诱导综上所述,我们假设HIV-1有助于
通过放大诱导的莫尔-1X选择性剪接的速率,
吗啡。我们提出的研究将揭示吗啡和艾滋病毒之间的一种新的协同作用,
OPRM 1前体mRNA的选择性剪接导致莫尔-1X同种型的优先表达,
对吗啡身体依赖的影响。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Modulation of OPRM1 Alternative Splicing by Morphine and HIV-1 Nef.
- DOI:10.1007/s11481-021-10009-4
- 发表时间:2022-06
- 期刊:
- 影响因子:0
- 作者:Donadoni M;Huang W;Yarandi SS;Burdo TH;Chang SL;Sariyer IK
- 通讯作者:Sariyer IK
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections.
- DOI:10.1007/s13365-023-01133-3
- 发表时间:2023-04
- 期刊:
- 影响因子:3.2
- 作者:Swingler, Michael;Donadoni, Martina;Bellizzi, Anna;Cakir, Senem;Sariyer, Ilker K.
- 通讯作者:Sariyer, Ilker K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SULIE L. CHANG其他文献
SULIE L. CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SULIE L. CHANG', 18)}}的其他基金
Effects of binge ethanol on neuroinflammation and neurodegeneration with high fat diets
暴饮乙醇对高脂肪饮食引起的神经炎症和神经变性的影响
- 批准号:
10668068 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Involvement of microglial α7AChR in binge alcohol modulation of gut dysbiosis
小胶质细胞α7AChR参与酗酒调节肠道菌群失调
- 批准号:
10705750 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Involvement of microglial α7AChR in binge alcohol modulation of gut dysbiosis
小胶质细胞α7AChR参与酗酒调节肠道菌群失调
- 批准号:
10527744 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Methylation in binge ethanol-induced spleen atrophy in adolescent rats
青春期大鼠暴食乙醇引起的脾萎缩的甲基化
- 批准号:
10400702 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
Immunomodulation of nicotine in HIV-1Tg rat brain
尼古丁对 HIV-1Tg 大鼠脑的免疫调节作用
- 批准号:
9897503 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
Immunomodulation of nicotine in HIV-1Tg rat brain
尼古丁对 HIV-1Tg 大鼠脑的免疫调节作用
- 批准号:
10378566 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
Methylation in binge ethanol-induced spleen atrophy in adolescent rats
青春期大鼠暴食乙醇引起的脾萎缩的甲基化
- 批准号:
10155374 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
Alcohol-induced Impairment of Endothelial Cell Recovery
酒精引起的内皮细胞恢复损伤
- 批准号:
9238541 - 财政年份:2017
- 资助金额:
$ 34.54万 - 项目类别:
Involvement of TRP Channels in Ethanol Concentration-Dependent Effects on Immune
TRP 通道参与乙醇浓度依赖性免疫效应
- 批准号:
8740695 - 财政年份:2014
- 资助金额:
$ 34.54万 - 项目类别:
Involvement of TRP Channels in Ethanol Concentration-Dependent Effects on Immune
TRP 通道参与乙醇浓度依赖性免疫效应
- 批准号:
8936414 - 财政年份:2014
- 资助金额:
$ 34.54万 - 项目类别:
相似海外基金
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
- 批准号:
10677284 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10464020 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Strategy for specific delivery of antisense oligonucleotides to T cells
将反义寡核苷酸特异性递送至 T 细胞的策略
- 批准号:
10547347 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10806783 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10689248 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10501862 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10623180 - 财政年份:2022
- 资助金额:
$ 34.54万 - 项目类别:
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
- 批准号:
BB/V019848/1 - 财政年份:2021
- 资助金额:
$ 34.54万 - 项目类别:
Research Grant














{{item.name}}会员




